English
  • Notice: Undefined variable: sectorLink in Drupal\five_paisa\Controller\StockDetailController->getSectorLink() (line 450 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'stockName' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 348 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Warning: Illegal string offset 'NSEcode' in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Uninitialized string offset: 0 in Drupal\five_paisa\Controller\StockDetailController->getData() (line 349 of modules/custom/five_paisa/src/Controller/StockDetailController.php).
  • Notice: Undefined index: current_date in Drupal\futures_option\Controller\FuturesController->getOptionData() (line 398 of modules/custom/futures_option/src/Controller/FuturesController.php).
  • Warning: array_column() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 33 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_multisort(): Argument #1 is expected to be an array or a sort flag in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 34 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: array_slice() expects parameter 1 to be array, string given in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 36 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Warning: Invalid argument supplied for foreach() in Drupal\five_paisa\MFHoldingService->MFShareholdingTable() (line 52 of modules/custom/five_paisa/src/MFHoldingService.php).
  • Notice: Undefined index: open_price in Drupal\five_paisa\StockService::openPrevData() (line 3918 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: prev_close in Drupal\five_paisa\StockService::openPrevData() (line 3919 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: vol in Drupal\five_paisa\StockService::openPrevData() (line 3923 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_low in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3901 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: fiftytwo_high in Drupal\five_paisa\StockService::fiftyLowHighData() (line 3902 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_low in Drupal\five_paisa\StockService::dayLowData() (line 3884 of modules/custom/five_paisa/src/StockService.php).
  • Notice: Undefined index: day_high in Drupal\five_paisa\StockService::dayLowData() (line 3885 of modules/custom/five_paisa/src/StockService.php).
  1. Home
  2. Stocks
  3. Eiko Share Price
  • Chart
  • Financials
  • Technicals
  • Volume
  • Result
  • Synopsis
  • Corp Action
  • MF Shareholding
  • Similar Stocks
  • FAQs

    • Eiko Lifesciences

    Small Cap
    ₹49.35
    +0.45 (0.92%)
    01 July, 2024 07:19 BSE: 540204 NSE: EIKOISIN: INE666Q01016

    Start SIP in Eiko Lifesciences

    Start SIP

    Eiko Lifesciences Performance

    Day Range

    • Low 0
    • High 0
    ₹ 49

    52 Week Range

    • Low 0
    • High 0
    ₹ 49
    • Open Price0
    • Previous Close0
    • Volume

    Eiko Lifesciences Share Price

    • Over 1 Month -5.02%
    • Over 3 Month -4.55%
    • Over 6 Month -22.96%
    • Over 1 Year -9.1%

    Eiko Lifesciences Key Statistics

    Eiko Lifesciences Financials
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr 87677
    Operating Expenses Qtr Cr 86666
    Operating Profit Qtr Cr 10000
    Depreciation Qtr Cr 00000
    Interest Qtr Cr 00000
    Tax Qtr Cr 00000
    Net Profit Qtr Cr 00000
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr 2819
    Operating Expenses Annual Cr 2617
    Operating Profit Annual in Cr 21
    Depreciation Cr 11
    Interest Annual Cr 00
    Tax Annual Cr 00
    Net Profit Annual Cr 11
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr -74
    Cash from Investing Activity Annual Cr -11
    Cash from Financing Annual Activity Cr 20-5
    Net Cash Flow Annual Cr 0
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr 5129
    Fixed Assets Annual Cr 1414
    Total Non Current Assets Annual Cr 2222
    Total Current Assets Annual Cr 319
    Total Assets Annual Cr 5331
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs 3935
    ROE Annual % 13
    ROCE Annual % 24
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin % 610
    IndicatorMar 2024Dec 2023Sep 2023Jun 2023Mar 2023
    Oper Rev Qtr Cr
    Operating Expenses Qtr Cr
    Operating Profit Qtr Cr
    Depreciation Qtr Cr
    Interest Qtr Cr
    Tax Qtr Cr
    Net Profit Qtr Cr
    IndicatorMar 2024Mar 2023
    Total Revenue Annual Cr
    Operating Expenses Annual Cr
    Operating Profit Annual in Cr
    Depreciation Cr
    Interest Annual Cr
    Tax Annual Cr
    Net Profit Annual Cr
    IndicatorMar 2024Mar 2023
    Cash from Operating Activity Annual Cr
    Cash from Investing Activity Annual Cr
    Cash from Financing Annual Activity Cr
    Net Cash Flow Annual Cr
    IndicatorMar 2024Mar 2023
    Total ShareHolders Funds Annual Cr
    Fixed Assets Annual Cr
    Total Non Current Assets Annual Cr
    Total Current Assets Annual Cr
    Total Assets Annual Cr
    IndicatorMar 2024Mar 2023
    Book Value Per Share Annual Rs
    ROE Annual %
    ROCE Annual %
    Total Debt to Total Equity Annual --
    EBDIT Annual Margin %
    Invest in Eiko Lifesciences

    Eiko Lifesciences Technicals

    EMA & SMA

    Current Price
    ₹49.35
    +0.45 (0.92%)
    pointer
    • Bullish Moving Average
    • ___
    • 0
    • Bearish Moving Average
    • ___
    • 16
    • 20 Day
    • ₹50.09
    • 50 Day
    • ₹51.78
    • 100 Day
    • ₹54.44
    • 200 Day
    • ₹56.63
    • 20 Day
    • ₹49.87
    • 50 Day
    • ₹51.69
    • 100 Day
    • ₹55.76
    • 200 Day
    • ₹58.54

    Eiko Lifesciences Resistance and Support

    PIVOT
    ₹49.82
    Resistance
    First Resistance 50.43
    Second Resistance 51.52
    Third Resistance 52.13
    RSI 44.91
    MFI 67.34
    MACD Single Line -0.58
    MACD -0.48
    Support
    First Support 48.73
    Second Support 48.12
    Third Supoort 47.03

    Eiko Lifesciences Delivery and Volume

    Period NSE + BSE Volume Avg NSE + BSE Delivery Volume Avg NSE + BSE Delivery Volume %
    Day 15,122 1,123,262 74.28
    Week 18,230 1,529,099 83.88
    1 Month 17,474 1,492,462 85.41
    6 Month 33,288 2,566,183 77.09

    Eiko Lifesciences Result Highlights

    Eiko Lifesciences Synopsis

    BSE-Chemicals-Specialty

    Eiko Lifesciences is involved in the business activities of Manufacture of organic and inorganic chemical compounds. Company’s Total Operating Revenue is Rs. 27.93 Cr. and Equity Capital is Rs. 12.87 Cr. for the Year ended 31/03/2024. Eiko Lifesciences Ltd. is a Public Limited Listed company incorporated on 07/01/1977 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L65993MH1977PLC258134 and registration number is 258134.
    Market Cap 49
    Sales 28
    Shares in Float 0.76
    No of funds
    Yield 0.34
    Book Value 1.25
    U/D Vol ratio 0.6
    LTDebt / Equity
    Alpha -0.12
    Beta 0.78

    Eiko Lifesciences Shareholding Pattern

    Owner NameMar-24Dec-23Sep-23
    Promoters 24.23%24.23%24.23%
    Individual Investors 51.61%54.06%54.94%
    Others 24.16%21.71%20.83%

    Eiko Lifesciences Management

    Name Designation
    Mr. Laxmikant Ramprasad Kabra Chairman & Non-Exe.Director
    Mr. Bhavesh Dhirajlal Tanna Non Executive Director
    Mr. Mandar Kamalakar Patil Independent Director
    Mr. Umesh Ravindranath More Whole Time Director
    Mr. Rajkumar Govindas Baheti Independent Director
    Mr. Kajal Dhanpatraj Kothari Independent Director

    Eiko Lifesciences Forecast

    Price Estimates

    2,000(9.8%)
    1,758(-3.5%)
    1,590(-12.7%)

    Other Analyst Rating

    Eiko Lifesciences Corporate Action

    Date Purpose Remarks
    2024-05-13 Audited Results
    2024-02-08 Quarterly Results
    2023-12-14 Others Re.0.00 1) Matter relating to payment of First and final call money on 55,44,178 partly paid-up equity shares of face value of Re. 10/- each which were issued and allotted on August 02, 2023.
    2023-11-08 Quarterly Results
    2023-07-11 Quarterly Results

    Eiko Lifesciences MF Shareholding

    Name Amount(cr)

    Eiko Lifesciences FAQs

    What is Share Price of Eiko Lifesciences ?

    Eiko Lifesciences share price is ₹49 As on 01 July, 2024 | 07:05

    What is the Market Cap of Eiko Lifesciences ?

    The Market Cap of Eiko Lifesciences is ₹49.2 Cr As on 01 July, 2024 | 07:05

    What is the P/E ratio of Eiko Lifesciences ?

    The P/E ratio of Eiko Lifesciences is 65.5 As on 01 July, 2024 | 07:05

    What is the PB ratio of Eiko Lifesciences ?

    The PB ratio of Eiko Lifesciences is 1 As on 01 July, 2024 | 07:05

    Q2FY23
    Open Free Demat Account

    Be a part of 5paisa community - The first listed discount broker of India.

    +91
     

    More Information

    CIN: L67190MH2007PLC289249 | Stock Broker SEBI Regn.: INZ000010231 | SEBI RA Regn.: INH000004680 | SEBI Depository Regn.: IN DP CDSL: IN-DP-192-2016 | AMFI REGN No.: ARN-104096 | NSE Member id: 14300 | BSE Member id: 6363 | MCX Member ID: 55945 | Investment Adviser Regn No: INA000014252 | Registered Address - IIFL House, Sun Infotech Park, Road no. 16V, Plot no. B-23, MIDC, Thane Industrial Area, Waghle Estate, Thane, Maharashtra - 400604

    *Brokerage will be levied flat fee/executed order basis and not on a percentage basis. Flat fee of Rs. 10/order is available with Power Investor & Ultra Trader Packs. Investment in securities market are subject to market risk, read all related documents carefully before investing. Digital account would be opened after all procedure relating to IPV and client due diligence is completed. If sale/ purchase value of share of Rs.10/- or less, a maximum brokerage of 25 paisa per share may be collected. Brokerage will not exceed the SEBI prescribed limit.

    Compliance Officer: Ms. Namita Godbole, Email: support@5paisa.com, Support Desk Helpline: 8976689766

    Contact Us

    Attention Investors

    • 1. No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account.
    • 2. Message from Exchange(s): Prevent Unauthorised transactions in your account --> Update your mobile numbers/email IDs with your stock brokers. Receive information of your transactions directly from Exchange on your mobile/email at the end of the day. Issued in the interest of investors.
    • 3. Message from Depositories: a) Prevent Unauthorized Transactions in your demat account --> Update your mobile number with your Depository Participant. Receive alerts on your registered mobile for all debit and other important transactions in your demat account directly from CDSL on the same day issued in the interest of investors. b) KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.

    Email: support@5paisa.com

    Support Desk Helpline: 8976689766

    ©2024, 5Paisa Capital Ltd. All Rights Reserved. We are ISO 27001:2013 Certified.